Data on Immunoglobulins Reported by Julie Pique and Colleagues (Cognitive and academic outcomes in children with myelin oligodendrocyte glycoprotein antibody-associated disease).

A study conducted in Lyon, France, focused on the impact of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) on cognitive and academic outcomes in children. The research included 51 pediatric patients with MOGAD, showing that 39.5% required academic interventions post-diagnosis, such as academic accommodations or learning support. The study emphasized the importance of cognitive and academic assessments for children with MOGAD to support their educational success. The findings were published in Developmental Medicine & Child Neurology and recommended tailored educational planning for these children. [Extracted from the article]